Deepak Patel, MD | |
310 Cool Water Ct, Hopkinsville, KY 42240-8738 | |
(270) 632-4675 | |
(270) 632-4680 |
Full Name | Deepak Patel |
---|---|
Gender | Male |
Speciality | Psychiatry & Neurology - Psychiatry |
Location | 310 Cool Water Ct, Hopkinsville, Kentucky |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1609969369 | NPI | - | NPPES |
64031362 | Medicaid | KY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2084P0804X | Psychiatry & Neurology - Child & Adolescent Psychiatry | 36579 (Kentucky) | Secondary |
2084P0800X | Psychiatry & Neurology - Psychiatry | 36579 (Kentucky) | Primary |
Entity Name | Trigg County Hospital, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1538218680 PECOS PAC ID: 5193620805 Enrollment ID: O20031205000118 |
News Archive
Selten Pharma, Inc., a privatively held biopharmaceutical company focused on the development and commercialization of therapies for the treatment of rare diseases, announced today that its lead compound tacrolimus (SPI-026) has been granted Orphan Drug Designation by the U.S. Food & Drug Administration for the treatment of pulmonary arterial hypertension (PAH).
A team of University of Maryland scientists has paved the way for the development of new drug therapies to combat active and asymptomatic (latent) tuberculosis infections by characterizing the unique structure and mechanism of an enzyme in M. tuberculosis, the bacterium that causes the disease.
The U.S. Food and Drug Administration Agency (FDA) is still to make a desision on lung transplant treatment Pulminiq.
The Wall Street Journal reports on plans by the health insurer UnitedHealth Group Inc. to issue a report Thursday on managed care strategies that "it says will help cash-strapped states solve budget problems and doctor shortages that hobble the government health-care programs for the poor."
› Verified 8 days ago
Entity Name | Jennie Stuart Medical Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1235139312 PECOS PAC ID: 4183607252 Enrollment ID: O20040609001506 |
News Archive
Selten Pharma, Inc., a privatively held biopharmaceutical company focused on the development and commercialization of therapies for the treatment of rare diseases, announced today that its lead compound tacrolimus (SPI-026) has been granted Orphan Drug Designation by the U.S. Food & Drug Administration for the treatment of pulmonary arterial hypertension (PAH).
A team of University of Maryland scientists has paved the way for the development of new drug therapies to combat active and asymptomatic (latent) tuberculosis infections by characterizing the unique structure and mechanism of an enzyme in M. tuberculosis, the bacterium that causes the disease.
The U.S. Food and Drug Administration Agency (FDA) is still to make a desision on lung transplant treatment Pulminiq.
The Wall Street Journal reports on plans by the health insurer UnitedHealth Group Inc. to issue a report Thursday on managed care strategies that "it says will help cash-strapped states solve budget problems and doctor shortages that hobble the government health-care programs for the poor."
› Verified 8 days ago
Entity Name | Trigg County Hospital, Inc |
---|---|
Entity Type | Part A Provider - Critical Access Hospital |
Entity Identifiers | NPI Number: 1538218680 PECOS PAC ID: 5193620805 Enrollment ID: O20080103000025 |
News Archive
Selten Pharma, Inc., a privatively held biopharmaceutical company focused on the development and commercialization of therapies for the treatment of rare diseases, announced today that its lead compound tacrolimus (SPI-026) has been granted Orphan Drug Designation by the U.S. Food & Drug Administration for the treatment of pulmonary arterial hypertension (PAH).
A team of University of Maryland scientists has paved the way for the development of new drug therapies to combat active and asymptomatic (latent) tuberculosis infections by characterizing the unique structure and mechanism of an enzyme in M. tuberculosis, the bacterium that causes the disease.
The U.S. Food and Drug Administration Agency (FDA) is still to make a desision on lung transplant treatment Pulminiq.
The Wall Street Journal reports on plans by the health insurer UnitedHealth Group Inc. to issue a report Thursday on managed care strategies that "it says will help cash-strapped states solve budget problems and doctor shortages that hobble the government health-care programs for the poor."
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Deepak Patel, MD Po Box 1567, Hopkinsville, KY 42241-1567 Ph: (270) 632-4675 | Deepak Patel, MD 310 Cool Water Ct, Hopkinsville, KY 42240-8738 Ph: (270) 632-4675 |
News Archive
Selten Pharma, Inc., a privatively held biopharmaceutical company focused on the development and commercialization of therapies for the treatment of rare diseases, announced today that its lead compound tacrolimus (SPI-026) has been granted Orphan Drug Designation by the U.S. Food & Drug Administration for the treatment of pulmonary arterial hypertension (PAH).
A team of University of Maryland scientists has paved the way for the development of new drug therapies to combat active and asymptomatic (latent) tuberculosis infections by characterizing the unique structure and mechanism of an enzyme in M. tuberculosis, the bacterium that causes the disease.
The U.S. Food and Drug Administration Agency (FDA) is still to make a desision on lung transplant treatment Pulminiq.
The Wall Street Journal reports on plans by the health insurer UnitedHealth Group Inc. to issue a report Thursday on managed care strategies that "it says will help cash-strapped states solve budget problems and doctor shortages that hobble the government health-care programs for the poor."
› Verified 8 days ago
Dr. Steven Lee Thore, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 737b North Drive, Hopkinsville, KY 42240 Phone: 270-890-1780 Fax: 270-890-1789 | |
John Timothy Ebert, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 105b West 18th Street, Hopkinsville, KY 42240 Phone: 270-889-0567 Fax: 270-889-9048 | |
Nusrat Siddiqi, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2400 Russellville Rd, Hopkinsville, KY 42240 Phone: 270-889-6025 Fax: 270-886-4487 | |
John B Stea, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2400 Russellville Rd, Hopkinsville, KY 42240 Phone: 270-889-6025 Fax: 270-886-4487 | |
Nayyar Iqbal, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2400 Russellville Rd, Hopkinsville, KY 42240 Phone: 270-889-6025 Fax: 270-886-4487 | |
Faisal Siddiqui, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2400 Russellville Rd, Hopkinsville, KY 42240 Phone: 270-889-6025 Fax: 270-886-4487 |